Multi-center clinical trial for Japanese children with bilateral nephroblastoma(RTBL14)
- Conditions
- nephroblastoma
- Registration Number
- JPRN-UMIN000020748
- Lead Sponsor
- Japan Children's Cancer Group(JCCG) (Japan Wilms Tumor Study Group, JWiTS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 17
Not provided
Cases with one of the following factors 1)Recurrent disease 2)Active double cancer, synchronous or remission less than 5 years 3)Performance Status (ECOG/Zubrod Score) is 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) 4)Severe organ failure (hematologic, liver, kidney, heart) White blood cells < 2000/mm3 Platelets <100,000/mm3 Serum bilirubin > 2.5 x normal limit Serum ALT > 2.5 x normal limit Serum total bile acid > 2.5 x normal limit Serum creatinine > 2.5 x normal limit 5) Patient unable to undergo chemotherapy due to other disease, or the attending doctor considers inappropriate to entry this study. 6)The patient has a psychological disorder so that unable for entry. 7)Patient unable to tolerate the chemotherapy for any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method